In animal models genetically modified to express the mutated APP that causes AD (APP KM670/671NL, Swedish; APP (716V, Florida; APP V171I, London)), cathepsin B concentration was evaluated at the protein and gene levels, and are increased ~50% in the cortex and hippocampus compared to a control group without the mutation [23]. Here, CTSB is linked to Alzheimer disease.